Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B

Journal of Proteome Research

Volumn 9, Issue 1, 2010, Pages 6-21

  Slany, Astrid ^a   Haudek, Verena J ^a   Zwickl, Hannes ^a   Gundacker, Nina C ^a   Grusch, Michael ^a   Weiss, Thomas S ^b   Seir, Katja ^c   Rodgarkia Dara, Chantal ^a   Hellerbrand, Claus ^b   Gerner, Christopher ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF APPLIED SCIENCES   (Austria)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

2D PAGE; Biomarker; CPL MUW database; LC MS MS; Liver cancer

Indexed keywords

BIOLOGICAL MARKER; FOLLISTATIN RELATED PROTEIN; FOLLISTATIN RELATED PROTEIN 1; LIVER PROTEIN; PROTEOME; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL STRAIN HEP3B; CELL STRAIN HEPG2; CELL TRANSFORMATION; FIBROBLAST; HUMAN; HUMAN CELL; LIVER CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UNINDEXED SEQUENCE;

ALPHA-FETOPROTEINS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELLS, CULTURED; CYTOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEPATOCYTES; HUMANS; LIVER NEOPLASMS; MASS SPECTROMETRY; PEPTIDE MAPPING; PROTEOME; REPRODUCIBILITY OF RESULTS;

EID: 73649144226     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900057t     Document Type: Article

References (62)

1. Masters, J. R. HeLa cells 50 years on: the good, the bad and the ugly. Nat. Rev. Cancer 2002, 2 (4), 315-9.
2. Celis, J. E.; Gromov, P. Proteomics in translational cancer research: toward an integrated approach. Cancer Cell 2003, 3 (1), 9-15.
3. Tyers, M.; Mann, M. From genomics to proteomics. Nature 2003, 422 (6928), 193-7.
4. Aden, D. P.; Fogel, A.; Plotkin, S.; Damjanov, I.; Knowles, B. B. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979, 282 (5739), 615-6.
5. Castell, J. V.; Jover, R.; Martinez-Jimenez, C. P.; Gomez-Lechon, M. J. Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opin. Drug Metab. Toxicol. 2006, 2 (2), 183-212.
6. Hiron, M.; Daveau, M.; Arnaud, P.; Bauer, J.; Lebreton, J. P. The human hepatoma Hep3B cell line as an experimental model in the study of the long-term regulation of acute-phase proteins by cytokines. Biochem. J. 1992, 287 (1), 255-9.
7. Lancon, A.; Hanet, N.; Jannin, B.; Delmas, D.; Heydel, J. M.; Lizard, G.; Chagnon, M. C.; Artur, Y.; Latruffe, N. Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes. Drug Metab. Dispos. 2007, 35 (5), 699-703.
8. Liu, J.; Kuznetsova, L. A.; Edwards, G. O.; Xu, J.; Ma, M.; Purcell, W. M.; Jackson, S. K.; Coakley, W. T. Functional three-dimensional HepG2 aggregate cultures generated from an ultrasound trap: comparison with HepG2 spheroids. J. Cell. Biochem. 2007, 102 (5), 1180-9.
9. Kim, W. K.; In, Y. J.; Kim, J. H.; Cho, H. J.; Kim, J. H.; Kang, S.; Lee, C. Y.; Lee, S. C. Quantitative relationship of dioxin-responsive gene expression to dioxin response element in Hep3B and HepG2 human hepatocarcinoma cell lines. Toxicol. Lett. 2006, 165 (2), 174-81.
10. Jiang, C.; Zhou, B.; Fan, K.; Heung, E.; Xue, L.; Liu, X.; Kirschbaum, M.; Yen, Y. A sequential treatment of depsipeptide followed by 5-azacytidine enhances Gadd45beta expression in hepatocellular carcinoma cells. Anticancer Res. 2007, 27 (6B), 3783-9.
11. Olsavsky, K. M.; Page, J. L.; Johnson, M. C.; Zarbl, H.; Strom, S. C.; Omiecinski, C. J. Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol. Appl. Pharmacol. 2007, 222 (1), 42-56.
12. Fujii, K.; Kondo, T.; Yokoo, H.; Yamada, T.; Iwatsuki, K.; Hirohashi, S. Proteomic study of human hepatocellular carcinoma using twodimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 2005, 5 (5), 1411-22.
13. Lee, C. L.; Hsiao, H. H.; Lin, C. W.; Wu, S. P.; Huang, S. Y.; Wu, C. Y.; Wang, A. H.; Khoo, K. H. Strategic shotgun proteomics approach for efficient construction of an expression map of targeted protein families in hepatoma cell lines. Proteomics 2003, 3 (12), 2472-86.
14. Seow, T. K.; Liang, R. C.; Leow, C. K.; Chung, M. C. Hepatocellular carcinoma: from bedside to proteomics. Proteomics 2001, 1 (10), 1249-63.
15. Yamashita, R.; Fujiwara, Y.; Ikari, K.; Hamada, K.; Otomo, A.; Yasuda, K.; Noda, M.; Kaburagi, Y. Extracellular proteome of human hepatoma cell, HepG2 analyzed using two-dimensional liquid chromatography coupled with tandem mass spectrometry. Mol. Cell. Biochem. 2007, 298 (1-2), 83-92.
16. Beigel, J.; Fella, K.; Kramer, P. J.; Kroeger, M.; Hewitt, P. Genomics and proteomics analysis of cultured primary rat hepatocytes. Toxicol. in Vitro 2008, 22 (1), 171-81.
17. Pan, C.; Kumar, C.; Bohl, S.; Klingmueller, U.; Mann, M. Comparative proteomic phenotyping of cell lines and primary cells to assess preservation of cell type specific functions. Mol. Cell. Proteomics 2008.
18. Gotzmann, J.; Mikula, M.; Eger, A.; Schulte-Hermann, R.; Foisner, R.; Beug, H.; Mikulits, W. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat. Res. 2004, 566 (1), 9-20.
19. Meindl-Beinker, N. M.; Dooley, S. Transforming growth factorbeta and hepatocyte transdifferentiation in liver fibrogenesis. J. Gastroenterol. Hepatol. 2008, 23 (1), S122-7.
20. Crane, L. J.; Miller, D. L. Plasma protein synthesis by isolated rat hepatocytes. J. Cell Biol. 1977, 72 (1), 11-25.
21. Tjalsma, H.; Bolhuis, A.; Jongbloed, J. D.; Bron, S.; van Dijl, J. M. Signal peptide-dependent protein transport in Bacillus subtilis: a genome-based survey of the secretome. Microbiol. Mol. Biol. Rev. 2000, 64 (3), 515-47.
22. Greenbaum, D.; Luscombe, N. M.; Jansen, R.; Qian, J.; Gerstein, M. Interrelating different types of genomic data, from proteome to secretome: 'oming in on function. Genome Res. 2001, 11 (9), 1463-8.
23. Gundacker, N.; Bayer, E.; Traxler, E.; Zwickl, H.; Kubicek, M.; Stockl, J.; Gerner, C. Knowledge-based proteome profiling: considering identified proteins to evaluate separation efficiency by 2-D PAGE. Electrophoresis 2006, 27 (13), 2712-21.
24. Gundacker, N. C.; Haudek, V. J.; Wimmer, H.; Slany, A.; Griss, J.; Bochkov, V.; Zielinski, C.; Wagner, O.; Stockl, J.; Gerner, C. Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells. J. Proteome Res. 2009, 8 (6), 2799-811.
25. Wimmer, H.; Gundacker, C. N.; Griss, J.; Haudek, V. J.; Stettner, S.; Mohr, T.; Zwickl, H.; Paulitschke, V.; Baron, D. M.; Trittner, W.; Kubicek, M.; Bayer, E.; Slany, A.; Gerner, C. Introducing the CPL/ MUW proteome database: Interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells. Electrophoresis 2009, 30 (12), 2076-89.
26. Griss, J.; Gerner, C. GPDE: a biological view on PRIDE. J. Proteomics Bioinf. 2009, 2, 167-74.
27. Paulitschke, V.; Kunstfeld, R.; Mohr, T.; Slany, A.; Micksche, M.; Drach, J.; Zielinski, C.; Pehamberger, H.; Gerner, C. Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells. J. Proteome Res. 2009, 8 (5), 2501-10.
28. Weiss, T. S.; Jahn, B.; Cetto, M.; Jauch, K. W.; Thasler, W. E. Collagen sandwich culture affects intracellular polyamine levels of human hepatocytes. Cell Proliferation 2002, 35 (5), 257-67.
29. Frazier, M. L.; Pathak, S.; Wang, Z. W.; Cleary, K.; Singletary, S. E.; Olive, M.; Mackay, B.; Steck, P. A.; Levin, B. Establishment of a new human pancreatic adenocarcinoma cell line, MDAPanc-3. Pancreas 1990, 5 (1), 8-16.
30. Gerner, C.; Gotzmann, J.; Frohwein, U.; Schamberger, C.; Ellinger, A.; Sauermann, G. Proteome analysis of nuclear matrix proteins during apoptotic chromatin condensation. Cell Death Differ. 2002, 9 (6), 671-81.
31. Rabilloud, T.; Strub, J. M.; Luche, S.; van Dorsselaer, A.; Lunardi, J. A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels. Proteomics 2001, 1 (5), 699-704.
32. Zwickl, H.; Traxler, E.; Staettner, S.; Parzefall, W.; Grasl-Kraupp, B.; Karner, J.; Schulte-Hermann, R.; Gerner, C. A novel technique to specifically analyze the secretome of cells and tissues. Electrophoresis 2005, 26 (14), 2779-85.
33. Mortz, E.; Krogh, T. N.; Vorum, H.; Gorg, A. Improved silver staining protocols for high sensitivity protein identification using matrixassisted laser desorption/ionization-time of flight analysis. Proteomics 2001, 1 (11), 1359-63.
34. Jones, P.; Cote, R. G.; Cho, S. Y.; Klie, S.; Martens, L.; Quinn, A. F.; Thorneycroft, D.; Hermjakob, H. PRIDE: new developments and new datasets. Nucleic Acids Res. 2008, 36, D878-83.
35. Jones, P.; Cote, R. G.; Martens, L.; Quinn, A. F.; Taylor, C. F.; Derache, W.; Hermjakob, H.; Apweiler, R. PRIDE: a public repository of protein and peptide identifications for the proteomics community. Nucleic Acids Res. 2006, 34, D659-63.
36. Zhang, B.; Chambers, M. C.; Tabb, D. L. Proteomic parsimony through bipartite graph analysis improves accuracy and transparency. J. Proteome Res. 2007, 6 (9), 3549-57.
37. Bendtsen, J. D.; Nielsen, H.; von Heijne, G.; Brunak, S. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 2004, 340 (4), 783-95.
38. Aoki-Kinoshita, K. F.; Kanehisa, M. Gene annotation and pathway mapping in KEGG. Methods Mol. Biol. 2007, 396, 71-91.
39. Uniprot-Consortium. The universal protein resource (UniProt). Nucleic Acids Res. 2008, 36, D190-5.
40. Mohr, T.; Haudek, V. J.; Gundacker, N. C.; Slany, A.; Wimmer, H.; Griss, J.; Schmid, R.; Wagner, O.; Micksche, M.; Gerner, C. Proteome and secretome profiles of angiogenic and inflammatory activated human endothelial cells: contribution to a systematic biomarker discovery approach. Mol. Cell Proteomics 2009, submitted for publication.
41. Mohr, T.; Haudek, V. J.; Gundacker, N. C.; Wimmer, H.; Griss, J.; Feng, Y.; Micksche, M.; Gerner, C. Cytoplasmic proteome and secretome profiles of angiogenic and inflammatory activated Human Umbilical Vein Endothelial Cells (HUVEC). J. Proteome Res. 2009, submitted for publication.
42. Diamandis, E. P. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell. Proteomics 2004, 3 (4), 367-78.
43. Zolg, W. The proteomic search for diagnostic biomarkers: lost in translation. Mol. Cell. Proteomics 2006, 5 (10), 1720-6.
44. Miyasaka, Y.; Enomoto, N.; Nagayama, K.; Izumi, N.; Marumo, F.; Watanabe, M.; Sato, C. Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br. J. Cancer 2001, 85 (2), 228-34.
45. Jia, H. L.; Ye, Q. H.; Qin, L. X.; Budhu, A.; Forgues, M.; Chen, Y.; Liu, Y. K.; Sun, H. C.; Wang, L.; Lu, H. Z.; Shen, F.; Tang, Z. Y.; Wang, X. W. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin. Cancer Res. 2007, 13 (4), 1133-9.
46. Hashimoto, K.; Mori, N.; Tamesa, T.; Okada, T.; Kawauchi, S.; Oga, A.; Furuya, T.; Tangoku, A.; Oka, M.; Sasaki, K. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepato-cellular carcinomas by conventional CGH and array CGH. Mod. Pathol. 2004, 17 (6), 617-22.
47. Zeng, Z. J.; Yang, L. Y.; Ding, X.; Wang, W. Expressions of cysteinerich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance. World J. Gastroenterol. 2004, 10 (23), 3414-8.
48. Alexia, C.; Fallot, G.; Lasfer, M.; Schweizer-Groyer, G.; Groyer, A. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis. Biochem. Pharmacol. 2004, 68 (6), 1003-15.
49. Scharf, J. G.; Dombrowski, F.; Ramadori, G. The IGF axis and hepatocarcinogenesis. Mol. Pathol. 2001, 54 (3), 138-44.
50. Breuhahn, K.; Schirmacher, P. Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma. World J. Gastroenterol. 2008, 14 (11), 1690-8.
51. Filmus, J.; Capurro, M. Glypican-3 and alphafetoprotein as diagnostic tests for hepatocellular carcinoma. Mol. Diagn. 2004, 8 (4), 207-12.
52. Wang, H. L.; Anatelli, F.; Zhai, Q. J.; Adley, B.; Chuang, S. T.; Yang, X. J. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions. Arch. Pathol. Lab. Med. 2008, 132 (11), 1723-8.
53. Qin, X.; Zhang, H.; Zhou, X.; Wang, C.; Zhang, H.; Zhang, X.; Ye, L. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells. Transl. Res. 2007, 150 (5), 281-94.
54. Kikkawa, Y.; Sudo, R.; Kon, J.; Mizuguchi, T.; Nomizu, M.; Hirata, K.; Mitaka, T. Laminin alpha 5 mediates ectopic adhesion of hepatocellular carcinoma through integrins and/or Lutheran/basal cell adhesion molecule. Exp. Cell Res. 2008, 314 (14), 2579-90.
55. Ramaiah, S. K.; Rittling, S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol. Sci. 2008, 103 (1), 4-13.
56. Tseng, P. L.; Tai, M. H.; Huang, C. C.; Wang, C. C.; Lin, J. W.; Hung, C. H.; Chen, C. H.; Wang, J. H.; Lu, S. N.; Lee, C. M.; Changchien, C. S.; Hu, T. H. Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients. J. Surg. Oncol. 2008, 98 (5), 349-57.
57. Clark, H. F.; Gurney, A. L.; Abaya, E.; Baker, K.; Baldwin, D.; Brush, J.; Chen, J.; Chow, B.; Chui, C.; Crowley, C.; Currell, B.; Deuel, B.; Dowd, P.; Eaton, D.; Foster, J.; Grimaldi, C.; Gu, Q.; Hass, P. E.; Heldens, S.; Huang, A.; Kim, H. S.; Klimowski, L.; Jin, Y.; Johnson, S.; Lee, J.; Lewis, L.; Liao, D.; Mark, M.; Robbie, E.; Sanchez, C.; Schoenfeld, J.; Seshagiri, S.; Simmons, L.; Singh, J.; Smith, V.; Stinson, J.; Vagts, A.; Vandlen, R.; Watanabe, C.; Wieand, D.; Woods, K.; Xie, M. H.; Yansura, D.; Yi, S.; Yu, G.; Yuan, J.; Zhang, M.; Zhang, Z.; Goddard, A.; Wood, W. I.; Godowski, P.; Gray, A. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003, 13 (10), 2265-70.
58. Law, A. Y.; Lai, K. P.; Ip, C. K.; Wong, A. S.; Wagner, G. F.; Wong, C. K. Epigenetic and HIF-1 regulation of stanniocalcin-2 expression in human cancer cells. Exp. Cell Res. 2008, 314 (8), 1823-30.
59. Iida, H.; Honda, M.; Kawai, H. F.; Yamashita, T.; Shirota, Y.; Wang, B. C.; Miao, H.; Kaneko, S. Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma. Gut 2005, 54 (6), 843-51.
60. Frierson, H. F., Jr.; Moskaluk, C. A.; Powell, S. M.; Zhang, H.; Cerilli, L. A.; Stoler, M. H.; Cathro, H.; Hampton, G. M. Largescale molecular and tissue microarray analysis of mesothelin expression in common human carcinomas. Hum. Pathol. 2003, 34 (6), 605-9.
61. Illman, S. A.; Lehti, K.; Keski-Oja, J.; Lohi, J. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J. Cell Sci. 2006, 119 (18), 3856-65.
62. Haudek, V. J.; Gundacker, N. C.; Slany, A.; Wimmer, H.; Bayer, E.; Pable, K.; Gerner, C. Consequences of acute and chronic oxidative stress upon the expression pattern of proteins in peripheral blood mononuclear cells. J. Proteome Res. 2008, 7 (12), 5138-47.